Comparative Survival in Patients With Postresection Recurrent Versus Newly Diagnosed Non-Small-Cell Lung Cancer Treated With Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1100-1105

  Cai, Xu Wei ^a,d,e   Xu, Lu Ying ^a   Wang, Li ^a   Hayman, James A ^a   Chang, Andrew C ^a   Pickens, Allan ^a   Cease, Kemp B ^b   Orringer, Mark B ^a   Kong, Feng Ming ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

chemotherapy; Non small cell lung cancer; postresection recurrence; radiotherapy; survival

Indexed keywords

CHEMORADIOTHERAPY; CONFIDENCE INTERVAL; COX REGRESSION; HAZARD RATIO; KAPLAN-MEIER; MEDIAN SURVIVAL; MEDICAL CENTER; MULTI VARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; POSTRESECTION RECURRENCE; PROGNOSTIC FACTORS; PROGRESSION FREE SURVIVAL; RADIATION ONCOLOGY; SURVIVAL ANALYSIS;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DECISION MAKING; MULTIVARIANT ANALYSIS; ONCOLOGY; PATIENT MONITORING; REGRESSION ANALYSIS;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMORADIOTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; SURVIVAL TIME;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 77449111926     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.017     Document Type: Article

References (26)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Gilbert S., Reid K.R., Lam M.Y., et al. Who should follow up lung cancer patients after operation?. Ann Thorac Surg 69 (2000) 1696-1700
3. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
4. al-Kattan K., Sepsas E., Fountain S.W., et al. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 12 (1997) 380-384
5. Battafarano R.J., Piccirillo J.F., Meyers B.F., et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 123 (2002) 280-287
6. Gabler A., and Liebig S. Reoperation for bronchial carcinoma. Thorax 35 (1980) 668-670
7. Watanabe Y., Shimizu J., Oda M., et al. Second surgical intervention for recurrent and second primary bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg 26 (1992) 73-78
8. Voltolini L., Paladini P., Luzzi L., et al. Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma. Eur J Cardiothorac Surg 18 (2000) 529-534
9. Shaw E.G., Brindle J.S., Creagan E.T., et al. Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc 67 (1992) 1129-1133
10. Curran Jr. W.J., Herbert S.H., Stafford P.M., et al. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?. Int J Radiat Oncol Biol Phys 24 (1992) 25-30
11. Leung J., Ball D., Worotniuk T., et al. Survival following radiotherapy for postsurgical locoregional recurrence of non-small-cell lung-cancer. Lung Cancer 13 (1995) 121-127
12. Emami B., Graham M.V., Deedy M., et al. Radiation therapy for intrathoracic recurrence of non-small cell lung cancer. Am J Clin Oncol 20 (1997) 46-50
13. Kagami Y., Nishio M., Narimatsu N., et al. Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer. Lung Cancer 20 (1998) 31-35
14. Jeremic B., Shibamoto Y., Milicic B., et al. External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection. Lung Cancer 23 (1999) 135-142
15. Foo K., Gebski V., Yeghiaian-Alvandi R., et al. Outcome following radiotherapy for loco-regionally recurrent non-small cell lung cancer. Australas Radiol 49 (2005) 108-112
16. Sugimura H., Nichols F.C., Yang P., et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 83 408 (2007) 409-417
17. Tada T., Fukuda H., Nakagawa K., et al. Non-small cell lung cancer: Radiation therapy for locoregional recurrence after complete resection. Int J Clin Oncol 10 (2005) 425-428
18. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
19. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597
20. Douillard J.Y., Rosell R., De Lena M., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 7 (2006) 719-727
21. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
22. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
23. Dillman R.O., Herndon J., Seagren S.L., et al. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
24. Kim T.Y., Yang S.H., Lee S.H., et al. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer. Am J Clin Oncol 25 (2002) 238-243
25. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
26. Socinski M.A., Rosenman J.G., Halle J., et al. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: A modified phase I/II trial. Cancer 92 (2001) 1213-1223